Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sienna Announces October Dividend
-
iMD Companies and Its Subsidiary Riize Health Announce New Product Lines: Riize Hair & Riize Weight Maintenance
-
Hudson Technologies to Host Conference Call to Discuss Third Quarter 2024 Results
-
Great Pacific Gold Increases Drilling Program at Kesar to 5,000 meters; Two Diamond Drill Rigs Mobilized to Site
-
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
-
GLOBAL MOFY AI LIMITED Announces $2.5 Million Private Placement Financing
-
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection
-
FOXO TECHNOLOGIES INC., PROVIDES UPDATE ON 2024 ACCOMPLISHMENTS AND PLANS FOR REMAINDER OF THE YEAR
-
SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week
-
Trio Provides Operational Update
-
iMD Companies and Its Subsidiary Riize Health Announce New Product Lines: Riize Hair & Riize Weight Maintenance
-
Complete Solar Appoints Solar Industry Veteran Dan Myers Executive Vice President of New Homes Division
-
Be Merry and Keep Saving with the Coolest Gifts at Five Below
-
89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024
-
Workhorse W56 Extended Wheelbase Model Achieves FMVSS and HVIP Certification, Now in Full Production for Q4 2024 Deliveries
-
ETC Announces Fiscal 2025 Second Quarter Results
-
CVR Energy to Release Third Quarter 2024 Earnings Results
-
CVR Partners to Release Third Quarter 2024 Earnings Results
-
HeartCore Partners with NTT Data Business Brains Corporation to Enhance its Website Development Service Capabilities
-
Adaptive Research Launches Decentralized Clinical Trial in Parkinson’s Disease
-
Circana Reveals Value-Based Deals, Not Just Price, Drive 54 Billion Global Foodservice Visits
-
Statkraft AS - Successful placement of dual-currency green bonds
-
Major shareholder announcement
-
Progressive Reports September 2024 Results
-
Alliance Witan PLC - Net Asset Value
-
Arbutus Announces Multiple Abstracts Highlighting Imdusiran Data Accepted for Presentation at AASLD - The Liver Meeting® 2024
-
Plantro enters into Agreement with Blacksheep Fund Management
-
STRATA Skin Sciences’ XTRAC® Excimer Laser was Focus of Two Lectures at Major Japanese Annual Dermatology Conference
-
NEWTON GOLF Company Expands its Global Presence with the Launch of Newton Motion Shafts in Japan
-
Form 8.3 - Learning Technologies Group Plc
-
Form 8.3 - Keywords Studios Plc
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Douglas Dynamics Announces Third Quarter 2024 Earnings Release and Conference Call
-
Seanergy Maritime Issues Investor Presentation Highlighting Value Creation Strategy
-
NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)
-
MaxCyte Appoints Cynthia Collins to its Board of Directors
-
Prime Matter Labs Names Four Industry Leaders to New Advisory Board
-
Taboola Introduces Abby, An Industry First Generative AI Assistant, Enabling Advertisers to “Talk to Abby” to Start and Manage Every Aspect of Advertising Campaigns
-
Noom Strengthens Healthcare Team by Adding Women’s Health Experts
-
Microchip Releases 20 Advanced Wi-Fi® Products for Industrial and Commercial Applications
-
Xometry to Announce Third Quarter 2024 Financial Results On November 5, 2024
-
WALKER RIVER ANNOUNCES ADDITIONAL RESULTS FROM THE LAPON GOLD PROJECT
-
Cleanfarms Collecting Unwanted Agricultural Pesticides and Old Livestock/Equine Medications in Southern Alberta starting in October
-
Franklin Electric Schedules Its Third Quarter 2024 Earnings Release and Conference Call
-
Xtreme One Entertainment Lets Retail Investors Get into the Fight Game with a $10 million Common Stock Offering to Accelerate its XFC 3-Year Growth Plan
-
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week
-
VELUX Group signs long-term agreement with ArcelorMittal to supply low carbon-emission steel
-
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
-
4VITAHEALTH™ Launches Groundbreaking Mental Health Supplements
-
BioVie Receives Notice of Allowance for Japan Patent Application Covering Novel Liquid Formulation of Terlipressin
